shutterstock_1739736104_Feb 8 2021_grayscale_2.jpg

Visionary Healthcare Investors

BioStar Capital is making a difference in patients' lives with uncompromising fund performance.



Medical Team 2.png

Business Acumen Meets

Clinical Expertise

The BioStar team represents a unique collaboration between experienced investment professionals and clinicians with global reputations as medical thought leaders.

                                                                                >> MEET THE TEAM


Innovations with an Impact

For over 17 years, BioStar Capital has been at the forefront of transformational medical technology through partnerships with innovative companies.

                                                                                                               >> VIEW OUR PORTFOLIO

Portfolio News

January 18, 2022

Foldax Appoints Scott Huennekens to Board of Directors

    >> Read More

January 5, 2022

Senseonics expects FDA approval for next-gen 180-day CGM in ‘coming weeks’

    >> Read More

BioStar News

May 25, 2021

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence

    >> Read More

January 15, 2021

DeviceTalks Weekly features Mark Toland, BioStar Entrepreneur-in-Residence: Digging into the Digital Medtech & Surgical Worlds

    >> Read More